Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulka B Campbell

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Therapeutic Innovation & Regulatory Science|July 18, 2025
Hope is Not a Strategy: Using Robust Real-World Evidence to Make Better Clinical Development DecisionsNicolle M Gatto, Ulka B Campbell
Epidemiologic Perspectives & Innovations : EP+I|August 4, 2010
Redundant causation from a sufficient cause perspectiveNicolle M Gatto, Ulka B Campbell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinenceUlka B Campbell, Paul Stang, Rich Barron
Annals of Epidemiology|June 24, 2017
Heeding the call for less casual causal inferences: the utility of realized (quantitative) causal effectsSharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Annals of Epidemiology|May 31, 2016
Causal identification: a charge of epidemiology in danger of marginalizationSharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Clinical Pharmacology and Therapeutics|August 8, 2023
SURF: A Screening Tool (for Sponsors) to Evaluate Whether Using Real-World Data to Support an Effectiveness Claim in an FDA Application Has Regulatory FeasibilityUlka B Campbell, Nicholaas Honig, Nicolle M Gatto
Epidemiologic Perspectives & Innovations : EP+I|March 5, 2005
Distributional interaction: Interpretational problems when using incidence odds ratios to assess interactionUlka B Campbell, Nicolle M Gatto, Sharon Schwartz
Epidemiologic Perspectives & Innovations : EP+I|April 5, 2012
Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA)Sharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Epidemiologic Perspectives & Innovations : EP+I|August 28, 2010
Author's response to Poole, C. Commentary: How Many Are Affected? A Real Limit of EpidemiologyNicolle M Gatto, Ulka B Campbell, Sharon Schwartz
Epidemiology (Cambridge, Mass.)|November 27, 2013
An organizational schema for epidemiologic causal effectsNicolle M Gatto, Ulka B Campbell, Sharon Schwartz
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Therapeutic Innovation & Regulatory Science|July 18, 2025
Hope is Not a Strategy: Using Robust Real-World Evidence to Make Better Clinical Development DecisionsNicolle M Gatto, Ulka B Campbell
Epidemiologic Perspectives & Innovations : EP+I|August 4, 2010
Redundant causation from a sufficient cause perspectiveNicolle M Gatto, Ulka B Campbell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 9, 2008
Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinenceUlka B Campbell, Paul Stang, Rich Barron
Annals of Epidemiology|June 24, 2017
Heeding the call for less casual causal inferences: the utility of realized (quantitative) causal effectsSharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Annals of Epidemiology|May 31, 2016
Causal identification: a charge of epidemiology in danger of marginalizationSharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Clinical Pharmacology and Therapeutics|August 8, 2023
SURF: A Screening Tool (for Sponsors) to Evaluate Whether Using Real-World Data to Support an Effectiveness Claim in an FDA Application Has Regulatory FeasibilityUlka B Campbell, Nicholaas Honig, Nicolle M Gatto
Epidemiologic Perspectives & Innovations : EP+I|March 5, 2005
Distributional interaction: Interpretational problems when using incidence odds ratios to assess interactionUlka B Campbell, Nicolle M Gatto, Sharon Schwartz
Epidemiologic Perspectives & Innovations : EP+I|April 5, 2012
Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA)Sharon Schwartz, Nicolle M Gatto, Ulka B Campbell
Epidemiologic Perspectives & Innovations : EP+I|August 28, 2010
Author's response to Poole, C. Commentary: How Many Are Affected? A Real Limit of EpidemiologyNicolle M Gatto, Ulka B Campbell, Sharon Schwartz
Epidemiology (Cambridge, Mass.)|November 27, 2013
An organizational schema for epidemiologic causal effectsNicolle M Gatto, Ulka B Campbell, Sharon Schwartz
Pageof 3